Clinical Trial Update: Ziprasidone in Early Onset Schizophrenia Spectrum Disorders [Phase 2]

View source ↗

Summary

Phase 2 study of Ziprasidone in early onset schizophrenia spectrum disorders conducted by the University of North Carolina has completed. The document notes the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED